Biomica Announces Agreement with Sheba Medical Center for Joint Microbiome Clinical Research

The research will be focused on developing new treatments for Inflammatory Bowel Disease (IBD) REHOVOT, Israel, April 13, 2022 /PRNewswire/ — Biomica Ltd. (Biomica), an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd….

No Comments

No comments yet.

Sorry, the comment form is closed at this time.